Abstract
With the current resurgence of efforts to improve and expand human vaccines, attention is again being focused on the development of safe and effective adjuvants (17). In particular, the utilization of synthetic antigenic determinants or ligands of low molecular weight, which are inherently weak antigenically, necessitates the use of adjuvant carriers for optimum efficiency.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ackerman, S. K. and Douglas, S. D., 1978, Purification of human monocytes on microexudate coated surfaces. J. Immunol. 120: 1372.
Allison, A. C. and Davies, A. J. S., 1971, Requirement of thymus dependent lymphocytes for potentiation by adjuvants of antibody formation. Nature 233: 330.
Baker, P. J., Hiernaux, J. R., Faunterloy, M. B., Prescott, B., Cantrell, J. L. and Rudbach, J. A., 1988, Inactivation of suppressor T cell activity by non-toxic monophosphoryl lipid A. Infect. Immun. 56: 1076.
Chedid, L., Audibert, F. and Bona, C., 1975, Adjuvant and mitogenic effects of detoxified lipopolysaccharides. CR. Acad. Sci. (Paris) 280: 1197.
Farrar, J. J., Fuller-Farrar, J., Simon, P. L., Hilfiker, M. L., Stadler, B. M. and Farrar, W. L., 1980, Thymoma production of T cell growth factor (interleukin 2). J. Immunol. 126: 1120.
Galanos, C., Luderitz, O. and Westphal, O., 1969, A new method for the extraction of R lipopolysaccharides. Eur. J. Immunol. 9: 245.
Gillis, S., Ferm, M. M., Ou, W. and Smith, K. A., 1978, T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120: 2027.
Goodman, M. G. and Weigle, W. O., 1985, Restoration of humoral immunity in vitro in immunodeficient aging mice by C8-derivatized guanine ribonucleosides. J. Immunol. 134: 3808.
Han, I. and Johnson, A., 1976, Regulation of the immune system by synthetic polynucleotides. VI. Amplification of the immune response in young and aging mice. J. Immunol. 117: 423.
Ho, M. K. and Springer, T. A., 1982, Mac-1 antigen: quantitative expression in macrophage populations and tissues and immunofluorescent localization in the spleen. J. Immunol. 128: 2281.
Johnson, A. G., Gaines, S. and Landy, M., 1956, Studies on the 0-antigen of Salmonella typhosa. V. Enhancement of the antibody response to protein antigens by the purified lipopolysaccharide. J. Exp. Med. 103: 225.
Johnson, A. G. and Nowotny, A., 1964, Relationship of structure to function in bacterial 0 antigens. III. Biological properties of endotoxoids. J. Bacteriol. 87: 809.
Kennedy, J. and Axelrad, M., 1971, An improved assay for hemolytic plaque forming cells. Immunology 20: 253.
Kishimoto, S., Takahama, T. and Mizumachi, H., 1976, In vitro immune response to the 2,4,6 trinitrophenyl determinant in aged C57 B1/6J mice: Changes in the humoral immune response to avidity for the TNP determinant and responsiveness to LPS effect with aging. J. Immunol. 116: 294.
Ly, I. A. and Mishell, R. I., 1974, Separation of mouse spleen cells by passage through columns of Sephadex G-10. J. Immunol. Methods 5: 239.
Mage, M. G., McHugh, L. L. and Rothstein, T. L., 1977, Mouse lymphocytes with and without surface immunoglobulin: Preparative scale separation in polystyrene tissue culture dishes coated with specifically purified anti-immunoglobulin. J. Immunol. Methods 15: 47.
Majde, J. A., 1987, Immunopharmacology of Infectious Diseases: Vaccine adjuvants and Modulators of Non-specific Resistance. Progess in Leukocyte Biology, Alan R. Liss Publishing, New York. ( Whole text cited).
Makinodan, T. and Peterson, W. J., 1962, Relative antibody forming capacity of spleen cells as a function of age. Proc. Natl. Acad. Sci. USA 48: 234.
McGhee, J. R., Farrar, J. J., Michalek, S. M., Mergenhagen, S. E. and Rosenstreich, D. L., 1979, Cellular requirements for lipopolysaccharide adjuvanticity. J. Exp. Med. 149: 793.
McIntire, F., Hargie, M., Schend, J., et al., 1976, Biological properties of non-toxic derivatives of a lipopolysaccharide from E. coli K235. J. Immunol. 117: 674.
Mishell, R. and Dutton, R., 1967, Immunization of dissociated spleen cell cultures in normal mice. J. Exp. Med. 126: 423.
Mizel, S. B., Rosenstreich, D. L. and Oppenheim, J. J., 1978, Phorbol myristicacetate stimulates LAF production by the macrophage cell line P388D1. Cell Immunol. 40: 230.
Morrison, D. and Ryan, J., 1979, Bacterial endotoxins and host immune responses. Adv. Immunol. 23: 293.
Nakano, M., Uchiyama, T. and Saito, K., 1973, Adjuvant effect of endotoxin: Antibody to sheep erythrocytes in mice after transfer of syngeneic lymhoid cells treated with bacterial lipopolysaccharide in vitro. J. Immunol. 110: 408.
Qureshi, N. and Takayama, K., 1982, Purification and structural determination of non-toxic lipid A obtained from the lipopolysaccharide of Salmonella typhimurium. J. Biol. Chem. 257: 11,808.
Qureshi, N., Mascagni, P., Ribi, E. and Takayama, K., 1985, Monophosphoryl lipid A obtained from lipopolysacharides of Salmonella minnesota 8595. Purification of the dimethyl derivative by high performance lipid chromatography and complete structural determination. J. Biol. Chem. 260: 5271.
Ribi, E., Cantrell, J. L., Takayama, K., Quereshi, N., Peterson, J. and Ribi, H. 0., 1984, Lipid A and Immunotherapy. Rev. Infect. Dis. 6: 567.
Ribi, E., Ulrich, J. T. and Masihi, K. N., in: “Immunopharmacology of Infectious Diseases,” J. A. Majde, ed., Alan R. Liss Publishing New York, p. 101.
Ribi, E., Cantrell, J., Feldner, T., Myers, K. and Peterson, J., 1986, Biological activities of monophosphoryl lipid A, in: “Microbiology, 1986,” L. Levine, P. F. Bonventre, J. A. Morello, F. D. Silver and H. C. Wu, eds., Amer. Soc. for Microbiol., Washington, D.C.
Rietschel, E. H., Brade, L., Schade, U., Zahringer, U. and Brade, H., 1987, Bacterial Endotoxins: Relation of Chemical Structure to Biological Activity, in: “Immunopharmacology of Infectious Diseases,” J. A. Majde, ed., Alan R. Liss Publishing, New York, p. 79.
Takayama, K., Ribi, E. and Cantrell, J. L., 1981, Isolation of a nontoxic lipid A fraction containing tumor regression activity. Cancer Res. 41: 2654.
Tomai, M. A., Solem, L. E., Johnson, A. G. and Ribi, E., 1987, The adjuvant properties of a non-toxic monophosphoryl lipid A in hyporesponsive and aging mice. J. Biol. Resp. Modifiers 6: 99.
Tomai, M. A., Johnson, A. G. and Ribi, E., 1988, Glycolipid induced proliferation of lipopolysaccharide hyporesponsive splenocytes. J. Leuk. Biol. 43: 11.
Vogel, S., Madonna, G., Wahl, L. and Rick, P., 1984, In vitro stimulation of C3H/HeJ spleen cells and macrophages by a lipid A precursor molecule derived from Salmonella typhimurium. J. Immunol. 132: 347.
Vogel, S. N., Hilfiker, M. L. and Caulfield, M. J., 1983, Endotoxin-induced T lymphocyte proliferation. J. Immunol. 130: 1774.
Vukajlovich, S. and Morrison, D., 1983, Conversion of lipopolysaccharides to molecular aggregates with reduced subunit heterogeneity - demonstration of LPS responsiveness in “endotoxin unresponsive” C3H/HeJ splenocytes. J. Immunol. 130: 2804.
Winchurch, R. A., Birmingham, W., Hilberg, C. and Munster, A., 1982, Effects of endotoxin on immunity in aging mice. Cell. Immunol. 67: 384.
Wysocki, L. J. and Sato, Y. L., 1978, Panning for lymphocytes: A method for cell selection. Proc. Natl. Acad. Sci. 75: 2844.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media New York
About this chapter
Cite this chapter
Johnson, A.G., Tomai, M.A. (1990). A Study of the Cellular and Molecular Mediators of the Adjuvant Action of a Nontoxic Monophosphoryl Lipid A. In: Friedman, H., Klein, T.W., Nakano, M., Nowotny, A. (eds) Endotoxin. Advances in Experimental Medicine and Biology, vol 256. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-5140-6_51
Download citation
DOI: https://doi.org/10.1007/978-1-4757-5140-6_51
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-5142-0
Online ISBN: 978-1-4757-5140-6
eBook Packages: Springer Book Archive